STOCK TITAN

Mark Sullivan to sell 10,702 shares (DFTX) under registered plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mark Sullivan reports intent to sell 10,702 shares of Common Stock on 03/25/2026. The filing lists the shares as restricted stock vesting under a registered plan and identifies the transaction as involving the issuer. The filing also discloses a prior sale of 11,276 shares on 12/26/2025.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice for a restricted stock vesting and planned sale.

The filing shows 10,702 shares of Common Stock listed for sale on 03/25/2026, described as restricted stock vesting under a registered plan. The method is identified as "Issuer" in the excerpt.

Past activity includes a sale of 11,276 shares on 12/26/2025. Transaction timing and precise cash‑flow treatment beyond the aggregate values shown are not provided in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for DFTX disclose about planned sales?

The Form 144 states the intention to sell 10,702 shares of Common Stock on 03/25/2026. It characterizes the shares as restricted stock vesting under a registered plan and lists the seller method as Issuer.

Did the filer report any recent sales before this Form 144?

Yes. The excerpt reports a prior sale of 11,276 shares of Common Stock on 12/26/2025. An aggregate dollar amount of $148,244.00 is shown for that past sale in the excerpt.

What is the aggregate value shown for the planned sale on 03/25/2026?

The excerpt shows an aggregate amount of $197,665.94 associated with a line that includes 10,702 shares and the date 03/25/2026. The filing ties the dollar figure to the securities line in the excerpt.

How are the shares described in the Form 144?

The shares are described as restricted stock vesting under a registered plan and the filing lists the transaction method as Issuer. The excerpt ties the vesting description to the planned sale date 03/25/2026.

Who is named as the selling or reporting party in the excerpt?

The excerpt lists Mark Sullivan with an address at One World Trade Center, Suite 8500, New York, NY. That name appears alongside the past sale entry dated 12/26/2025.
Definium Therapeutics

NASDAQ:DFTX

View DFTX Stock Overview

DFTX Rankings

DFTX Latest News

DFTX Latest SEC Filings

DFTX Stock Data

1.84B
96.87M
Biotechnology
Medicinal Chemicals & Botanical Products
Link
United States
NEW YORK